Aseptic Processing and Contamination Control Under EU GMP Annex 1: Practical Applications for Modern Sterile Operations
Learn how to apply EU GMP Annex 1 contamination control principles in practice — covering CCS, environmental monitoring signals, aseptic interventions, and sterility assurance decisions.
Instructor
Meredith Crabtree
GMP Quality Consultant & Validation Specialist
What You'll Learn
About the event
About this event
Aseptic processing operations continue to face increasing scrutiny as regulators place greater emphasis on contamination control, sterility assurance, intervention management, environmental monitoring, and the effectiveness of Contamination Control Strategies (CCS) under EU GMP Annex 1. While many organizations have updated procedures and implemented Annex 1 requirements, significant challenges often remain in translating regulatory expectations into practical operational decisions. Questions frequently arise around how contamination risks are evaluated, how interventions are managed, how monitoring data is interpreted, and whether existing controls genuinely support sterility assurance.
This session examines the practical application of Annex 1 principles within modern sterile manufacturing environments. The discussion will focus on the operational decisions that influence contamination control effectiveness, the interpretation of environmental and process signals, the management of aseptic risks, and the rationale behind critical quality decisions. Real-world examples will be used to explore how organizations can strengthen contamination control programs while maintaining practical and sustainable sterile operations.
WHY YOU SHOULD ATTEND
In sterile manufacturing, few decisions are made with complete information. Environmental monitoring results may appear inconclusive. Interventions may seem routine. Minor deviations may appear isolated. Yet many contamination investigations reveal that warning signs were present long before the event itself was recognized. Teams operating under EU GMP Annex 1 are increasingly expected to recognize and act upon those signals before contamination events, sterility concerns, or adverse trends become fully apparent.
Annex 1 places increasing emphasis on contamination control as an active process supported by an effective CCS rather than a collection of independent procedures. This requires organizations to evaluate risks continuously, interpret signals appropriately, and justify actions taken when certainty does not yet exist. This session focuses on the judgment, rationale, and decision-making that support effective contamination control within modern sterile operations and help organizations maintain confidence in sterility assurance.
Code: FDB1613
Curriculum
Requirements
- Working in sterile manufacturing, aseptic processing, or biopharmaceutical operations
- Applicable to quality, microbiology, validation, manufacturing, and regulatory affairs professionals
- Relevant to organizations implementing or strengthening EU GMP Annex 1 compliance programs
Who Should Attend
This session is designed for professionals working in sterile manufacturing and aseptic processing environments subject to EU GMP Annex 1. Essential for: Quality Assurance (QA), Sterile Manufacturing and Operations, Microbiology and Environmental Monitoring Personnel, Validation and Qualification Professionals, Quality Control (QC), Manufacturing Science and Technical Services (MS&T), Compliance and Quality Systems Professionals, and Regulatory Affairs and Sterile Product Leadership.
Areas Covered
Meet Your Instructor
Meredith Crabtree
GMP Quality Consultant & Validation Specialist
Meredith Crabtree has over 30 years' experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling and distribution operations. Meredith is the owner of MLKC Consulting and specializes in product label reviews, 3rd party inspections, Consent Decree and Recall support. She also performs regulatory assessments and Quality trainings.
Event Details
Format
Recorded Webinar
Duration
1.5 hours
Certificate
Included
Access
Lifetime
Related Events
Digital Quality Metrics and AI/ML Analytics: Building a Continuous-Improvement Framework that Aligns with Regulatory Expectations
Learn how AI/ML and real-time digital quality metrics build a continuous-improvement framework aligned with FDA regulatory expectations, 21 CFR Part 11, and GAMP®5.
Carolyn Troiano
AI in GMP: What the FDA Is Already Expecting - Before You Ask
FDA already expects GMP compliance for AI systems. Learn how existing validation, data integrity, and oversight rules apply—before regulators come calling.
Dr. Ginette Collazo
HPLC Analytical Method Development and Validation
Master HPLC instrument and method validation to meet US EPA and FDA requirements for pharmaceutical analysis.
Dr. John C. Fetzer